News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,300 Results
Type
Article (5098)
Company Profile (24)
Press Release (227178)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82290)
Career Advice (463)
Deals (15056)
Drug Delivery (8)
Drug Development (19075)
Employer Resources (30)
FDA (3701)
Job Trends (3912)
News (120254)
Policy (7524)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (295)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14820)
ALS (38)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (40)
Approvals (3801)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (98)
Best Places to Work (2866)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (886)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16683)
Collaboration (354)
Compensation (371)
Complete response letters (8)
COVID-19 (312)
CRISPR (13)
C-suite (338)
Cystic fibrosis (28)
Data (1327)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2122)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42749)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39161)
Executive appointments (424)
FDA (4440)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (340)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (144)
Government (426)
Guidances (197)
Healthcare (5051)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (338)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7880)
IRA (3)
Job creations (1124)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (11)
Layoffs (106)
Leadership (5)
Legal (2342)
Liver cancer (21)
Longevity (2)
Lung cancer (92)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (140)
MASH (50)
Medical device (3940)
Medtech (3950)
Mergers & acquisitions (7580)
Metabolic disorders (214)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (539)
NextGen: Class of 2026 (1675)
Non-profit (735)
Now hiring (5)
Obesity (84)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (51)
Patient recruitment (96)
Peanut (6)
People (25235)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4995)
Phase 2 (7226)
Phase 3 (5789)
Pipeline (1963)
Policy (17)
Postmarket research (625)
Preclinical (1947)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (179)
Real estate (1887)
Recruiting (8)
Regulatory (5541)
Reports (17)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (54)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1017)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Last 7 days (146)
Last 30 days (535)
Last 365 days (8890)
2026 (784)
2025 (9042)
2024 (11036)
2023 (13219)
2022 (18680)
2021 (19713)
2020 (18271)
2019 (13242)
2018 (10231)
2017 (10038)
2016 (9200)
2015 (12131)
2014 (9592)
2013 (7709)
2012 (8329)
2011 (8799)
2010 (8635)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11797)
Australia (1691)
California (3545)
Canada (1138)
China (167)
Colorado (143)
Connecticut (162)
Delaware (70)
Europe (25588)
Florida (541)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (105)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2803)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1018)
New Mexico (5)
New York (814)
North Carolina (479)
North Dakota (4)
Northern California (1854)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (281)
South Carolina (17)
Southern California (1307)
Tennessee (61)
Texas (480)
United States (12332)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,300 Results for "masimo corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies
September 12, 2025
·
3 min read
Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
Masimo Corporation issued a letter to stockholders in connection with the Company’s 2024 Annual Meeting of Stockholders.
July 1, 2024
·
14 min read
Masimo Announces Sleep Halo™, Advanced Sleep Analysis for the Masimo W1®
Masimo, announced that the Masimo W1® Sport advanced health tracking wearable is gaining a powerful new feature: scientifically based sleep analysis with Sleep Halo™.
July 1, 2024
·
9 min read
Press Releases
In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones
October 8, 2025
·
11 min read
Press Releases
Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters
August 19, 2025
·
9 min read
Press Releases
Masimo Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
July 9, 2025
·
5 min read
Business
Masimo Reports First Quarter 2024 Financial Results
Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 30, 2024.
May 7, 2024
·
26 min read
Biotech Beach
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
Masimo, a global leader in noninvasive monitoring technologies and audio products, announced that its Board of Directors has authorized management to evaluate a proposed separation of its consumer business.
March 22, 2024
·
8 min read
Biotech Beach
Masimo to Present in Jefferies Global Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 1:00 p.m. Eastern Time.
May 29, 2024
·
3 min read
Biotech Beach
Masimo Files Investor Presentation Highlighting Innovation-Driven Value, Strategic Initiatives to Deliver Robust Growth and Margin Expansion and Risks of Ceding Control to Politan
Masimo Corporation filed an investor presentation with the U.S. Securities and Exchange Commission in connection with its Annual Meeting of Stockholders to be held on July 25, 2024.
June 26, 2024
·
9 min read
1 of 23,230
Next
